Gerald Chi Selected Research

Gerald Chi Research Topics

Disease

15	Venous Thromboembolism 01/2021 - 01/2015
10	Hemorrhage 01/2021 - 01/2017
7	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2015
6	Acute Coronary Syndrome 03/2022 - 05/2016
6	Myocardial Infarction 01/2022 - 01/2016
6	Thrombosis (Thrombus) 01/2019 - 05/2016
6	Atrial Fibrillation 10/2018 - 01/2017
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2018
5	COVID-19 12/2021 - 08/2020
5	Pulmonary Embolism 01/2021 - 01/2015
5	Stroke (Strokes) 11/2018 - 05/2016
4	Inflammation (Inflammations) 07/2019 - 05/2018
3	Heart Failure 01/2020 - 01/2017
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2021
2	Ischemia 01/2018 - 01/2016
2	Ischemic Stroke 01/2017 - 01/2017
1	Brain Ischemia (Cerebral Ischemia) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Pulmonary Edema 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022
1	Infections 12/2021
1	Atherosclerosis 01/2021
1	Chest Pain (Chest Pains) 01/2020
1	Pregnancy Complications 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Malocclusion (Crossbite) 09/2018
1	Congenital Abnormalities (Deformity) 09/2018
1	Thrombophilia 05/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2018
1	ST Elevation Myocardial Infarction 01/2016
1	Infarction (Infarctions) 01/2016
1	Reperfusion Injury 01/2016

Drug/Important Bio-Agent (IBA)

12	fibrin fragment D (D-dimer)IBA 07/2021 - 01/2015
12	betrixabanIBA 01/2021 - 01/2017
8	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
6	AnticoagulantsIBA 01/2021 - 01/2018
5	RivaroxabanIBA 01/2021 - 01/2017
4	Vitamin K FDA Link 10/2018 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2018
2	Troponin IIBA 01/2022 - 01/2016
2	Biological ProductsIBA 01/2021 - 12/2018
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 04/2018
2	C-Reactive ProteinIBA 01/2019 - 11/2017
2	cupric sulfide (CuS)IBA 12/2018 - 01/2018
2	Warfarin (Coumadin)FDA LinkGeneric 10/2018 - 01/2018
2	Factor Xa InhibitorsIBA 10/2018 - 01/2017
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2018 - 01/2017
1	LDL CholesterolIBA 03/2022
1	LipidsIBA 01/2022
1	CholesterolIBA 01/2022
1	TroponinIBA 01/2022
1	ApoproteinsIBA 01/2022
1	MDCO-216IBA 01/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022
1	CSL112IBA 01/2022
1	trans-crotonin (CTN)IBA 01/2022
1	CER-001IBA 01/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2021
1	Chloroquine (Aralen)FDA LinkGeneric 12/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	Interleukin-27 (Interleukin 27)IBA 01/2021
1	HDL CholesterolIBA 01/2021
1	Illicit Drugs (Recreational Drugs)IBA 07/2019
1	Serum AlbuminIBA 01/2019
1	AlbuminsIBA 01/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Therapeutic UsesIBA 10/2018
1	AntithrombinsIBA 10/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2018
1	InterleukinsIBA 05/2018
1	DABIIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	hemoglobin ASIBA 01/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2017
1	pro-brain natriuretic peptide (1-76)IBA 11/2017
1	Natriuretic PeptidesIBA 01/2017
1	vorapaxarIBA 05/2016
1	MB Form Creatine KinaseIBA 01/2016
1	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 01/2016

Therapy/Procedure

11	Therapeutics 03/2022 - 01/2017
5	Percutaneous Coronary Intervention 01/2020 - 05/2016
3	Stents 05/2018 - 05/2016
2	Patient Readmission 01/2018 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 12/2021
1	Denervation 01/2020
1	Drug Therapy (Chemotherapy) 11/2018
1	Off-Label Use 10/2018
1	Osteotomy 09/2018
1	Vascular Closure Devices 01/2018